Personal information

India

Activities

Education and qualifications (5)

Manipal College of Pharmaceutical Sciences: Manipal, Karnataka, IN

2018-08-03 to 2022-08-08 | Ph.D Scholar (Pharmaceutics)
Education
Source: Self-asserted source
Akhil Suresh

Amrita College of Pharmaceutical Sciences: Kochi, Kerala, IN

2016-07-11 to 2018-06-11 | Master of Pharmacy (Pharmaceutics)
Education
Source: Self-asserted source
Akhil Suresh

Vignan Institute of Pharmaceutical Techonology: Visakhapatnam, Andhra Pradesh, IN

2012-08-10 to 2016-08-10 | Bachelor of Pharmacy (Pharmacy)
Education
Source: Self-asserted source
Akhil Suresh

Sri Chaitanya Junior College: Vijayawada, Andhra Pradesh, IN

2010-07-10 to 2012-07-10 | 12th (Biology, Physics & Chemistry)
Education
Source: Self-asserted source
Akhil Suresh

Delhi Public School : Visakhapatnam, Andhra Pradesh, IN

2000-03-10 to 2010-03-10 | 10th
Education
Source: Self-asserted source
Akhil Suresh

Professional activities (3)

Amrita College of Pharmaceutical Sciences: Kochi, Kerala, IN

Best in Research (Pharmaceutics)
Distinction
Source: Self-asserted source
Akhil Suresh

Amrita College of Pharmaceutical Sciences: Kochi, Kerala, IN

2018-09-20 | University Gold Medal (Pharmaceutics)
Distinction
Source: Self-asserted source
Akhil Suresh

Al Shifa College of Pharmacy: Perinthalmanna, Kerala, IN

2017 | Best Poster
Distinction
Source: Self-asserted source
Akhil Suresh

Works (15)

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment

Viruses
2023-01-12 | Journal article
Contributors: Varalakshmi Velagacherla; Akhil Suresh; Chetan Hasmukh Mehta; Usha Y. Nayak; Yogendra Nayak
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Hybrid nanostructures: Versatile systems for biomedical applications

Coordination Chemistry Reviews
2022-06 | Journal article
Contributors: Swapnil Mehta; Akhil Suresh; Yogendra Nayak; Reema Narayan; Usha Y Nayak
Source: check_circle
Crossref

Enhancing the oral bioavailability of asenapine maleate with bio-enhancer: An in-silico assisted in-vivo pharmacokinetic study

Journal of Drug Delivery Science and Technology
2022-04 | Journal article
Contributors: Akhil Suresh; Reema Narayan; Hari Prabhath Tummala; Saikumar Matcha; Surulivelrajan Mallayasamy; Yogendra Nayak; Jagadish Puralae Channabasavaiah; Usha Y. Nayak
Source: check_circle
Crossref

Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer

3 Biotech
2021-12 | Journal article
Contributors: Fiona C. Rodrigues; Gangadhar Hari; K. S. R. Pai; Akhil Suresh; Usha Y. Nayak; N. V. Anilkumar; Goutam Thakur
Source: check_circle
Crossref

Development of lapatinib nanosponges for enhancing bioavailability

Journal of Drug Delivery Science and Technology
2021-10 | Journal article
Part of ISSN: 1773-2247
Source: Self-asserted source
Akhil Suresh

Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy

Carbohydrate Polymers
2021-06 | Journal article
Part of ISSN: 0144-8617
Source: Self-asserted source
Akhil Suresh
grade
Preferred source (of 2)‎

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study

European Journal of Pharmacology
2021-04 | Journal article
Part of ISSN: 0014-2999
Source: Self-asserted source
Akhil Suresh
grade
Preferred source (of 2)‎

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19

Molecular Diversity
2021-02-13 | Journal article
Part of ISSN: 1381-1991
Part of ISSN: 1573-501X
Source: Self-asserted source
Akhil Suresh

Recent advances in the development of asenapine formulations

Expert Opinion on Drug Delivery
2020 | Journal article
EID:

2-s2.0-85087731305

Part of ISBN:

17447593 17425247

Contributors: Suresh, A.; Narayan, R.; Nayak, U.Y.
Source: Self-asserted source
Akhil Suresh via Scopus - Elsevier

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study

Archives of Medical Research
2020 | Journal article
EID:

2-s2.0-85091259245

Part of ISBN:

18735487 01884409

Contributors: Baby, K.; Maity, S.; Mehta, C.H.; Suresh, A.; Nayak, U.Y.; Nayak, Y.
Source: Self-asserted source
Akhil Suresh via Scopus - Elsevier

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2

Pharmaceutical Sciences
2020-11-30 | Journal article
Part of ISSN: 1735-403X
Part of ISSN: 2383-2886
Source: Self-asserted source
Akhil Suresh
grade
Preferred source (of 2)‎

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment

2020-11-03 | Other
Contributors: Varalakshmi Velagacherla; Akhil Suresh; Chetan H Mehta; Yogendra Nayak; Usha Y Nayak
Source: check_circle
Crossref

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19

F1000Research
2020-09-23 | Journal article
Part of ISSN: 2046-1402
Source: Self-asserted source
Akhil Suresh

Development and in vitro evaluation of nanolipid carriers of clobetasol propionate and pramoxine hydrochloride for topical delivery

International Journal of Applied Pharmaceutics
2018 | Journal article
EID:

2-s2.0-85047150585

Part of ISBN:

09757058

Contributors: Mohan, D.C.; Suresh, A.; Mukundan, S.; Gupta, S.; Viswanad, V.
Source: Self-asserted source
Akhil Suresh via Scopus - Elsevier

Sustained release timolol maleate loaded ocusert based on biopolymer composite

International Journal of Biological Macromolecules
2018 | Journal article
EID:

2-s2.0-85041615433

Part of ISBN:

18790003 01418130

Contributors: Nair, R.V.; S, S.; Suresh, A.; Anoop, K.R.; Nair, S.C.
Source: Self-asserted source
Akhil Suresh via Scopus - Elsevier